About Infugen Pharma
Infugen Pharma is a fully integrated pharmaceutical company providing high quality, affordable and innovative healthcare solutions. We primarily market a wide range of generic formulations in Indian and international market. In India, our generic formulations range is focused mainly on therapeutic areas of Gynaecology, Neurovascular segment and Surgical Critical Care. We also export precision engineered surgical equipments and diagnostics kits, in association with certified, quality manufacturers.

At Infugen, our quest for improving quality of life drives us to make a real difference to the lives of millions of people with our commitment to effective healthcare solutions. Which is why, we choose to partner only with the best in the industry.
Read More...
Our Products

Plant Tree Plant Hope
At Infugen, we have embraced the commitment to make a difference to our environment and build a sustainable
Read More...
News & Events



H1N1 flu pandemic is over, World Health Organization announces
The 2009 H1N1 influenza pandemic is officially over, according to the World Health Organization (WHO
Pharmexcil to conduct global CEO conclave, distribute awards on Sept 14
The Pharmaceutical Exports Promotion Council (Pharmexcil) is planning to organise a global conclave
ICH-Q proposes for technical guidance tripartite for development & production of APIs
International Conference for Harmonization on Quality (ICH-Q) Drug Substance team of experts has pro
CIPI to assist small cos for filing BA/BE documents for FDC drugs
Even as the small and medium pharma companies in the country are finding it difficult to get license
IPC to include more monographs of biopharma, excipients in IP
In an effort to cover wider spectrum of biological, vaccines, radio pharma and excipients to brought
DRL sees end of troubles from Betapharm
Betapharm, the German subsidiary which has been a drag for Dr Reddy's Laboratories after the latter
Dr Reddy's 1Q Net Profit Falls 14%, Misses Estimates
BANGALORE (Dow Jones)--Indian drug maker Dr. Reddy's Laboratories Ltd. (500124.BY) Thursday reported
DoP fails to break stalemate on the issue of imposing anti-dumping duty on Pen G
The Department of Pharmaceuticals' (DoP) efforts to break the stalemate over the controversial issue
DoP on talks with foreign universities for collaboration in R&D
In an effort to accelerate the pharmaceutical research and development activities in the country
Ayush dept issues draft notification on GCP for ASU & traditional medicines
The Department of Ayurveda, Unani, Siddha and Homoeopathy (Ayush) has recently issued a draft gazett
Forex Rate
INR / 1 Euro60.42
INR / 1 Pound Sterling72.73
INR / 1 USD46.19